Progenitor cells in the cerebral cortex sequentially generate distinct classes of projection neurons. Recent work suggests the cortex may contain intrinsically fate-restricted progenitors marked by expression of Cux2. However, the heterogeneity of the neocortical ventricular zone as well as the contribution of lineage-restricted progenitors to the overall cortical neurogenic program remains unclear. Here, we utilize in vivo genetic fate mapping to demonstrate that Fezf2-expressing radial glial cells (RGCs) exist throughout cortical development and sequentially generate all major projection neuron subtypes and glia. Moreover, we show that the vast majority of CUX2 + cells in the VZ and SVZ are migrating interneurons derived from the subcortical telencephalon. Examination of the embryonic cortical progenitor population demonstrates that Cux2 + RGCs generate both deep-and upper-layer projection neurons. These results identify Fezf2 + radial glial cells as a multipotent neocortical progenitor and suggest that the existence, and molecular identity, of laminar-fate-restricted RGCs awaits further investigation.
INTRODUCTION
The neocortex contains six layers of projection neurons and glia. Projection neurons in each cortical layer display similar morphologies, axonal projections, and gene expression patterns . During development, cortical projection neurons are generated from radial glial cells (RGCs) and basal progenitors in an inside-out pattern such that deep-layer neurons are generated first, followed by upper-layer neurons (Molyneaux et al., 2007) . Three decades of work based upon transplantation experiments (Desai and McConnell, 2000; McConnell, 1985; McConnell and Kaznowski, 1991) , viral lineage tracing (Luskin et al., 1988; Walsh and Cepko, 1988) , and in vitro culture of single RGCs (Shen et al., 2006) suggests that cortical projection neuron subtype is sequentially determined by birthdate through progressive lineage restriction of a common RGC (Leone et al., 2008) . However, the identification of early Cux2-expressing (Cux2 + ) RGCs, which were reported to be intrinsically specified to generate late-born, upper-layer neurons (Franco et al., 2012) , calls into question this decades-old model and raises the possibility that deep-layer projection neurons are similarly generated from lineage-restricted progenitors (Franco and Mü ller, 2013; Marín, 2012) . The transcription factor Fezf2 (also known as Fezl and Zfp312) is expressed in early cortical progenitors and deep-layer neurons and is critical for the fate specification of subcerebral projection neurons (Chen et al., 2005a (Chen et al., , 2005b Molyneaux et al., 2005) . In Fezf2 À/À mice, subcerebral projections are absent and deep-layer neurons instead switch their identity to become corticothalamic or callosal projection neurons (Chen et al., 2005a (Chen et al., , 2005b Han et al., 2011; McKenna et al., 2011; Molyneaux et al., 2005) . Several studies suggest that ectopic expression of Fezf2 in late cortical progenitors or immature neurons (De la Rossa et al., 2013; Rouaux and Arlotta, 2013) 
RESULTS

Lineage-Traced Fezf2-Expressing Progenitor Cells Are RGCs
We first characterized Fezf2 expression by in situ hybridization. As previously reported (Hirata et al., 2004) , we detected Fezf2 expression in early neocortical progenitors ( Figure 1B ). Interestingly, Fezf2 expression in the ventricular zone (VZ) persisted postnatally, long after deep-layer neuron generation has ceased (Figure S1A available online). This was confirmed by GFP expression in Fezf2-GFP bacterial artificial chromosome (BAC) transgenic mice (Gong et al., 2003; Shim et al., 2012) , which revealed GFP + cells in the VZ during late embryonic and early postnatal stages ( Figure S1B ). To assess the differentiation potential of Fezf2 + progenitor cells, we generated nine independent Fezf2-CreER T2 BAC transgenic mouse lines ( Figure 1A ). In situ hybridization for Cre and Fezf2 showed that Cre expression was identical to that of endogenous Fezf2 (Figures 1B and 1C; Figures S1C and S1D) . Breeding these mice to three different Cre reporter lines (RCE-GFP, R26R-LacZ, or TauR-mGFP; Friedrich and Soriano, 1991; Hippenmeyer et al., 2005; Sousa et al., 2009) 2D and 2L). Those in layer 5 expressed high levels of CTIP2 (also known as BCL11B), indicating a subcerebral neuron identity ( Figure 2C ). Many GFP + cells expressed the callosal neuron marker SATB2 and were observed in both deep and upper layers ( Figure 2D ).
Indeed, GFP-labeled axon tracts demonstrated that Fezf2
+ RGCs generated callosal, subcerebral, and corticothalamic projection neurons (Figures S2D-S2F ). In addition to projection neurons, 15% of GFP + cells showed an astrocytic morphology and expressed GFAP ( Figures 2E and 2Q (M-P) Immunohistochemical analysis of brains from TM at E18.5; P21 mice. GFP + cells included astrocytes (O) and oligodendrocytes (P).
(Q) Percentages of GFP + cells that were neurons, astrocytes, or oligodendrocytes ± SEM. *p < 0.05, **p < 0.005, ***p < 0.0001. Ctx, cerebral cortex; Hip, hippocampus; Thal, thalamus; TM, tamoxifen; WM, white matter. Scale bars: 500 mm (A, G, and M), 250 mm (B, H, and N), and 25 mm (F, K, and P). See also Figure S2 .
hemisphere showed that GFP + SATB2 + cells projected callosal axons . In TM at E18.5; P21 brains, only 2% of GFP + cells were projection neurons ( Figure 2Q ). Instead, the GFP + cells consisted of astrocytes (53%) 
Clonal Analysis of Fezf2 + RGCs
To further examine the lineage of Fezf2 + RGCs, we performed in vivo clonal analysis. Low-efficiency tamoxifen induction at E12.5 using the RCE-GFP reporter labeled putative RGC clones, which consisted of neurons in both deep and upper layers, astrocytes, and oligodendrocytes ( Figure S3A ). To extend our clonal analysis, we crossed Fezf2-CreER T2 mice to the Confetti reporter line (Snippert et al., 2010) , which enabled the identification of individual RGC clones based upon the exclusive expression of CFP, GFP, YFP or RFP. Early (TM at E12.5) Fezf2 + RGCs produced clones that consisted of neurons in deep and upper layers and glia (Figures 3A and 3B and Figures S3B and S3C) . In contrast, when tamoxifen was administered at E14.5, clones consisted of only upper-layer neurons and glia ( Figures 3C and 3D and Figures S3D and S3E ). Of note, we occasionally observed clones consisting of only glia ( Figure 3E ), consistent with previous viral-based clonal analysis of cortical progenitors (Luskin et al., 1988; Walsh and Cepko, 1988) . These results support the conclusion that Fezf2 + RGCs sequentially generate cortical projection neuron subtypes and glia.
CUX2
+ Cells in the VZ and SVZ Are Migrating
Interneurons Derived from the Ventral Telencephalon The finding that Fezf2 + RGCs contribute substantially to upperlayer neurogenesis is consistent with the classic progressive restriction model (Leone et al., 2008) . However, this is in contrast to a newly proposed model that suggests all upper-layer neurons are generated from Cux2 + RGCs (Franco and Mü ller, 2013) . To resolve this difference, we explored the relationship between Fezf2 + RGCs and CUX2 + cortical cells using two different CUX2 antibodies that recognize different regions of the CUX2 protein (Conforto et al., 2012; Iulianella et al., 2008; Laz et al., 2007) . We found that 72% of upper-layer neurons generated (Cobos et al., 2006; Cubelos et al., 2008a Cubelos et al., , 2008b Franco et al., 2011 Franco et al., , 2012 Nieto et al., 2004; Zimmer et al., 2004) , we detected robust CUX2 expression beginning at E14.5, including expression in neocortical interneurons ( Figure S4 ). We examined the relationship between Fezf2 + RGCs and CUX2 + progenitors using TM at E10.5; E15.5 Fezf2-CreER T2 ; RCE-GFP brains, since the Cux2 + RGC population was reported to peak at this age (Franco et al., 2012) . We found that although some CUX2 + cells resided in the VZ, the majority were in the SVZ ( Figure 4C ). We rarely observed GFP + CUX2 + cells in the VZ/SVZ ( Figure 4E ), and these cells were SOX2 À ( Figure 4D ), suggesting they were not (Franco et al., 2012) . To resolve this discrepancy, we obtained Cux2-Cre and Cux2-CreER T2 mice and analyzed them using RCE-GFP, Ai14, and Ai9 (Madisen et al., 2010) reporter lines. In the brains of E15.5 Cux2-Cre; RCE-GFP and Cux2-Cre; Ai14 embryos, many cells were labeled by GFP or TdTomato (Figures S5E and S5F ). Labeled cells in the neocortical VZ/SVZ expressed the RGC marker PAX6 (Figure S5G ) or the basal progenitor marker TBR2 ( Figure S5H) , consistent with the Cux2 in situ hybridization results (Figures S5A-S5D ; see also Franco et al., 2012) . Immunohistochemistry using CUX2 and CRE antibodies revealed that most of the lineage-traced cells in the VZ/SVZ did not express CUX2 or CRE protein ( Figures  S5J and S5K) , indicating that the Cre reporter system may be more sensitive than immunohistochemistry for detecting low levels of Cux2 expression. Aside from cortical progenitor cells, Cux2-Cre also labeled many neurons in the cortical plate that expressed CTIP2, a marker for early-born subcortical projection neurons ( Figure S5I ). We next investigated the lineage potential of Cux2 + RGCs using Cux2-CreER T2 ; Ai9 mice. In TM at E10.5; P0 brains, TdTomato + cells were observed throughout the brain ( Figure 4K ) including in both deep and upper cortical layers ( Figure 4L ). Indeed, within layers 2-6 of the neocortex, 29% and 26% of TdTomato + cells expressed the deep-layer markers CTIP2 and TBR1, respectively, whereas 30% expressed the upper-layer marker CUX1 ( Figures 4M-4S and S5N ). CTIP2 expression in TdTomato + cells in P0 Cux2-CreER T2 ; Ai9 brains is consistent with the observed expression in labeled cells of E15 Cux2-Cre brains ( Figure S5I ). In addition to CTIP2 and TBR1, TdTomato + cells also expressed NFIB and SOX5 ( Figures S5L and S5M) , both of which mark early-born subcortical projection neurons at P0 (Betancourt et al., 2013; Kwan et al., 2008; Lai et al., 2008; McKenna et al., 2011) . Collectively, these results demonstrate that early Cux2-Cre-and Cux2-CreER T2 -labeled neocortical RGCs are not lineage restricted, in that they generate both deep-and upper-layer projection neurons. allele induces recombination of the RCE-GFP reporter only in progenitor cells and not in postmitotic neurons. This was observed when tamoxifen or 4-hydroxytamoxifen was administered from E12 to adult stages. However, the Cux2-Cre and Cux2-CreER T2 alleles induced recombination in both progenitor cells and postmitotic neurons (Franco et al., 2011 (Franco et al., , 2012 , possibly masking the true lineage potential of Cux2 + progenitor cells. Furthermore, Fezf2 is not expressed in neocortical interneurons or their progenitors. In contrast, Cux2 is expressed at high levels in interneurons that are born in the subpallium and migrate into the neocortex (Cobos et al., 2006) .
DISCUSSION
Fezf2 Expression in Neocortical Progenitors
Fezf2 is essential for subcerebral neuron development (Chen et al., 2005a (Chen et al., , 2005b Han et al., 2011; McKenna et al., 2011; Molyneaux et al., 2005) . Indeed, overexpression of Fezf2 in late cortical progenitors redirects these cells to generate subcerebral projection neurons (Chen et al., 2005b Molyneaux et al., 2005) . Here, we demonstrate that, during normal brain development, Fezf2 is expressed in late RGCs as these cells are generating upper-layer projection neurons and glia. This suggests it is not simply Fezf2 expression, but rather its expression level, in RGCs that influences the differentiated cell types that are produced. Going forward it will be important to understand the mechanisms that precisely regulate Fezf2 transcription levels across different expression domains in order to functionally dissect its involvement in neocortical development.
Heterogeneity of Embryonic Neural Stem Cells
Previous studies suggest that neocortical RGCs are a heterogeneous cell population. Subsets of RGCs were reported to differentially express markers such as RC2, GLAST, and BLBP (Hartfuss et al., 2001 ). In addition, in vivo lineage analysis of neocortical progenitors using retroviral vectors produced clones that consisted of only neurons or glia (Luskin et al., 1988; Walsh and Cepko, 1988) , suggesting the existence of neuron-or glia-restricted progenitor cells. Furthermore, recent work indicates that the neocortical progenitor pool contains both outer radial glia cells (Hansen et al., 2010; Wang et al., 2011) as well as short neural precursors (Gal et al., 2006; Stancik et al., 2010; Tyler and Haydar, 2013) that are molecularly and morphologically distinct from ventricular zone RGCs.
Results from our study indicate that progressive lineage restriction of multipotent RGCs is a common mechanism for generating cellular diversity during cortical development. However, the finding that Cux2-Cre-and Cux2-CreER T2 -labeled
RGCs are not upper-layer, fate-restricted progenitors does not exclude the possibility that some cortical projection neurons may originate from fate-restricted RGCs. Indeed, our clonal analysis of Fezf2 + RGCs produced clones that consisted of only glial cells ( Figure 3B ), suggesting the possibility of lineage-restricted subpopulations within the Fezf2 + RGC population. Moreover, it is possible that Fezf2 + RGCs are a heterogeneous population in that some Fezf2 + RGCs may express Cux2 mRNA or protein at levels below the detection threshold of in situ hybridization or immunohistochemistry. Many genes expressed in RGCs have been identified (Molyneaux et al., 2007; Woodworth et al., 2012) . Genetic fate mapping using these loci will further expand our knowledge of progenitor cell heterogeneity within the neocortical progenitor pool and uncover the mechanisms that generate projection neuron diversity.
EXPERIMENTAL PROCEDURES
All experiments were carried out in accordance with protocols approved by the IACUC at University of California at Santa Cruz and were performed in accordance with institutional and federal guidelines. Fezf2-CreER T2 mice were generated according to previously established strategies (Lee et al., 2001 ) by modifying the RP23-141E17 BAC.
In situ hybridization and immunohistochemistry were performed as previously described (Eckler et al., 2011) . The rabbit anti-CUX2 antibody (Conforto et al., 2012; Laz et al., 2007 ) was a gift from Dr. David Waxman. We also confirmed CUX2 expression using a second rabbit anti-CUX2 antibody (Iulianella et al., 2008 (Iulianella et al., , 2009 ) kindly provided by Angelo Iulianella.
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